Reports

Industry Research Reports

Global C1 Esterase Inhibitor Market Research Report 2024

Global C1 Esterase Inhibitor Market Research Report 2024

Industry: Pharma & Healthcare

Published Date: 2024-01-05

Pages: 72 Pages

Report ld: 2139592

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

C1 Esterase Inhibitor Market Size(US$)

den_QYR1
cagr

CAGR 2024-2030

6.1%

marketSize

Market Size,2030

USD 194

Million

Market Snapshot

Market Size in 2024 (Value)
US$ 136 million
Market Forecast in 2030(Value)
US$ 194 million
CAGR
6.1%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood. 

The global C1 Esterase Inhibitor market was valued at US$ 128.6 million in 2023 and is anticipated to reach US$ 194 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.

The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.

This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor.

MARKET SEGMENTATION

By Company

  • CSL Behring
  • Takeda
  • Pharming Intellectual

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Human
  • Recombinant

Segment by Application

  • Hospital
  • Pharmacy

biaoTi REPORT SCOPE

The C1 Esterase Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global C1 Esterase Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the C1 Esterase Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Detailed analysis of C1 Esterase Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Sales, revenue of C1 Esterase Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 C1 Esterase Inhibitor Market Overview

1.1 Product Overview and Scope of C1 Esterase Inhibitor

1.2 C1 Esterase Inhibitor Segment by Type

1.2.1 Global C1 Esterase Inhibitor Market Value Comparison by Type (2024-2030)

1.2.2 Human

1.2.3 Recombinant

1.3 C1 Esterase Inhibitor Segment by Application

1.3.1 Global C1 Esterase Inhibitor Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Pharmacy

1.4 Global C1 Esterase Inhibitor Market Size Estimates and Forecasts

1.4.1 Global C1 Esterase Inhibitor Revenue 2019-2030

1.4.2 Global C1 Esterase Inhibitor Sales 2019-2030

1.4.3 Global C1 Esterase Inhibitor Market Average Price (2019-2030)

1.5 Assumptions and Limitations

muLu

2 C1 Esterase Inhibitor Market Competition by Manufacturers

2.1 Global C1 Esterase Inhibitor Sales Market Share by Manufacturers (2019-2024)

2.2 Global C1 Esterase Inhibitor Revenue Market Share by Manufacturers (2019-2024)

2.3 Global C1 Esterase Inhibitor Average Price by Manufacturers (2019-2024)

2.4 Global C1 Esterase Inhibitor Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of C1 Esterase Inhibitor, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of C1 Esterase Inhibitor, Product Type & Application

2.7 C1 Esterase Inhibitor Market Competitive Situation and Trends

2.7.1 C1 Esterase Inhibitor Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest C1 Esterase Inhibitor Players Market Share by Revenue

2.7.3 Global C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

muLu

3 C1 Esterase Inhibitor Retrospective Market Scenario by Region

3.1 Global C1 Esterase Inhibitor Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global C1 Esterase Inhibitor Global C1 Esterase Inhibitor Sales by Region: 2019-2030

3.2.1 Global C1 Esterase Inhibitor Sales by Region: 2019-2024

3.2.2 Global C1 Esterase Inhibitor Sales by Region: 2025-2030

3.3 Global C1 Esterase Inhibitor Global C1 Esterase Inhibitor Revenue by Region: 2019-2030

3.3.1 Global C1 Esterase Inhibitor Revenue by Region: 2019-2024

3.3.2 Global C1 Esterase Inhibitor Revenue by Region: 2025-2030

3.4 North America C1 Esterase Inhibitor Market Facts & Figures by Country

3.4.1 North America C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America C1 Esterase Inhibitor Sales by Country (2019-2030)

3.4.3 North America C1 Esterase Inhibitor Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.4.6 Mexico

3.5 Europe C1 Esterase Inhibitor Market Facts & Figures by Country

3.5.1 Europe C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe C1 Esterase Inhibitor Sales by Country (2019-2030)

3.5.3 Europe C1 Esterase Inhibitor Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific C1 Esterase Inhibitor Market Facts & Figures by Country

3.6.1 Asia Pacific C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific C1 Esterase Inhibitor Sales by Country (2019-2030)

3.6.3 Asia Pacific C1 Esterase Inhibitor Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America C1 Esterase Inhibitor Market Facts & Figures by Country

3.7.1 Latin America C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America C1 Esterase Inhibitor Sales by Country (2019-2030)

3.7.3 Latin America C1 Esterase Inhibitor Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa C1 Esterase Inhibitor Market Facts & Figures by Country

3.8.1 Middle East and Africa C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa C1 Esterase Inhibitor Sales by Country (2019-2030)

3.8.3 Middle East and Africa C1 Esterase Inhibitor Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

muLu

4 Segment by Type

4.1 Global C1 Esterase Inhibitor Sales by Type (2019-2030)

4.1.1 Global C1 Esterase Inhibitor Sales by Type (2019-2024)

4.1.2 Global C1 Esterase Inhibitor Sales by Type (2025-2030)

4.1.3 Global C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)

4.2 Global C1 Esterase Inhibitor Revenue by Type (2019-2030)

4.2.1 Global C1 Esterase Inhibitor Revenue by Type (2019-2024)

4.2.2 Global C1 Esterase Inhibitor Revenue by Type (2025-2030)

4.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)

4.3 Global C1 Esterase Inhibitor Price by Type (2019-2030)

muLu

5 Segment by Application

5.1 Global C1 Esterase Inhibitor Sales by Application (2019-2030)

5.1.1 Global C1 Esterase Inhibitor Sales by Application (2019-2024)

5.1.2 Global C1 Esterase Inhibitor Sales by Application (2025-2030)

5.1.3 Global C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)

5.2 Global C1 Esterase Inhibitor Revenue by Application (2019-2030)

5.2.1 Global C1 Esterase Inhibitor Revenue by Application (2019-2024)

5.2.2 Global C1 Esterase Inhibitor Revenue by Application (2025-2030)

5.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)

5.3 Global C1 Esterase Inhibitor Price by Application (2019-2030)

muLu

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Corporation Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CSL Behring C1 Esterase Inhibitor Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Takeda

6.2.1 Takeda Corporation Information

6.2.2 Takeda Description and Business Overview

6.2.3 Takeda C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Takeda C1 Esterase Inhibitor Product Portfolio

6.2.5 Takeda Recent Developments/Updates

6.3 Pharming Intellectual

6.3.1 Pharming Intellectual Corporation Information

6.3.2 Pharming Intellectual Description and Business Overview

6.3.3 Pharming Intellectual C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pharming Intellectual C1 Esterase Inhibitor Product Portfolio

6.3.5 Pharming Intellectual Recent Developments/Updates

muLu

7 Industry Chain and Sales Channels Analysis

7.1 C1 Esterase Inhibitor Industry Chain Analysis

7.2 C1 Esterase Inhibitor Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 C1 Esterase Inhibitor Production Mode & Process

7.4 C1 Esterase Inhibitor Sales and Marketing

7.4.1 C1 Esterase Inhibitor Sales Channels

7.4.2 C1 Esterase Inhibitor Distributors

7.5 C1 Esterase Inhibitor Customers

muLu

8 C1 Esterase Inhibitor Market Dynamics

8.1 C1 Esterase Inhibitor Industry Trends

8.2 C1 Esterase Inhibitor Market Drivers

8.3 C1 Esterase Inhibitor Market Challenges

8.4 C1 Esterase Inhibitor Market Restraints

muLu

9 Research Finding and Conclusion

muLu

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global C1 Esterase Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global C1 Esterase Inhibitor Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global C1 Esterase Inhibitor Market Competitive Situation by Manufacturers in 2023
Table 4. Global C1 Esterase Inhibitor Sales (K Unit) of Key Manufacturers (2019-2024)
Table 5. Global C1 Esterase Inhibitor Sales Market Share by Manufacturers (2019-2024)
Table 6. Global C1 Esterase Inhibitor Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global C1 Esterase Inhibitor Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market C1 Esterase Inhibitor Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of C1 Esterase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of C1 Esterase Inhibitor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of C1 Esterase Inhibitor, Product Type & Application
Table 12. Global Key Manufacturers of C1 Esterase Inhibitor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global C1 Esterase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global C1 Esterase Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global C1 Esterase Inhibitor Sales by Region (2019-2024) & (K Unit)
Table 18. Global C1 Esterase Inhibitor Sales Market Share by Region (2019-2024)
Table 19. Global C1 Esterase Inhibitor Sales by Region (2025-2030) & (K Unit)
Table 20. Global C1 Esterase Inhibitor Sales Market Share by Region (2025-2030)
Table 21. Global C1 Esterase Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global C1 Esterase Inhibitor Revenue Market Share by Region (2019-2024)
Table 23. Global C1 Esterase Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global C1 Esterase Inhibitor Revenue Market Share by Region (2025-2030)
Table 25. North America C1 Esterase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America C1 Esterase Inhibitor Sales by Country (2019-2024) & (K Unit)
Table 27. North America C1 Esterase Inhibitor Sales by Country (2025-2030) & (K Unit)
Table 28. North America C1 Esterase Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America C1 Esterase Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe C1 Esterase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe C1 Esterase Inhibitor Sales by Country (2019-2024) & (K Unit)
Table 32. Europe C1 Esterase Inhibitor Sales by Country (2025-2030) & (K Unit)
Table 33. Europe C1 Esterase Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe C1 Esterase Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific C1 Esterase Inhibitor Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific C1 Esterase Inhibitor Sales by Region (2019-2024) & (K Unit)
Table 37. Asia Pacific C1 Esterase Inhibitor Sales by Region (2025-2030) & (K Unit)
Table 38. Asia Pacific C1 Esterase Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific C1 Esterase Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America C1 Esterase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America C1 Esterase Inhibitor Sales by Country (2019-2024) & (K Unit)
Table 42. Latin America C1 Esterase Inhibitor Sales by Country (2025-2030) & (K Unit)
Table 43. Latin America C1 Esterase Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America C1 Esterase Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa C1 Esterase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa C1 Esterase Inhibitor Sales by Country (2019-2024) & (K Unit)
Table 47. Middle East & Africa C1 Esterase Inhibitor Sales by Country (2025-2030) & (K Unit)
Table 48. Middle East & Africa C1 Esterase Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa C1 Esterase Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global C1 Esterase Inhibitor Sales (K Unit) by Type (2019-2024)
Table 51. Global C1 Esterase Inhibitor Sales (K Unit) by Type (2025-2030)
Table 52. Global C1 Esterase Inhibitor Sales Market Share by Type (2019-2024)
Table 53. Global C1 Esterase Inhibitor Sales Market Share by Type (2025-2030)
Table 54. Global C1 Esterase Inhibitor Revenue (US$ Million) by Type (2019-2024)
Table 55. Global C1 Esterase Inhibitor Revenue (US$ Million) by Type (2025-2030)
Table 56. Global C1 Esterase Inhibitor Revenue Market Share by Type (2019-2024)
Table 57. Global C1 Esterase Inhibitor Revenue Market Share by Type (2025-2030)
Table 58. Global C1 Esterase Inhibitor Price (USD/Unit) by Type (2019-2024)
Table 59. Global C1 Esterase Inhibitor Price (USD/Unit) by Type (2025-2030)
Table 60. Global C1 Esterase Inhibitor Sales (K Unit) by Application (2019-2024)
Table 61. Global C1 Esterase Inhibitor Sales (K Unit) by Application (2025-2030)
Table 62. Global C1 Esterase Inhibitor Sales Market Share by Application (2019-2024)
Table 63. Global C1 Esterase Inhibitor Sales Market Share by Application (2025-2030)
Table 64. Global C1 Esterase Inhibitor Revenue (US$ Million) by Application (2019-2024)
Table 65. Global C1 Esterase Inhibitor Revenue (US$ Million) by Application (2025-2030)
Table 66. Global C1 Esterase Inhibitor Revenue Market Share by Application (2019-2024)
Table 67. Global C1 Esterase Inhibitor Revenue Market Share by Application (2025-2030)
Table 68. Global C1 Esterase Inhibitor Price (USD/Unit) by Application (2019-2024)
Table 69. Global C1 Esterase Inhibitor Price (USD/Unit) by Application (2025-2030)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. CSL Behring C1 Esterase Inhibitor Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Takeda Corporation Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Takeda C1 Esterase Inhibitor Product
Table 79. Takeda Recent Developments/Updates
Table 80. Pharming Intellectual Corporation Information
Table 81. Pharming Intellectual Description and Business Overview
Table 82. Pharming Intellectual C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Pharming Intellectual C1 Esterase Inhibitor Product
Table 84. Pharming Intellectual Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. C1 Esterase Inhibitor Distributors List
Table 88. C1 Esterase Inhibitor Customers List
Table 89. C1 Esterase Inhibitor Market Trends
Table 90. C1 Esterase Inhibitor Market Drivers
Table 91. C1 Esterase Inhibitor Market Challenges
Table 92. C1 Esterase Inhibitor Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Product Picture of C1 Esterase Inhibitor
Figure 2. Global C1 Esterase Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global C1 Esterase Inhibitor Market Share by Type in 2023 & 2030
Figure 4. Human Product Picture
Figure 5. Recombinant Product Picture
Figure 6. Global C1 Esterase Inhibitor Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global C1 Esterase Inhibitor Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global C1 Esterase Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global C1 Esterase Inhibitor Market Size (2019-2030) & (US$ Million)
Figure 12. Global C1 Esterase Inhibitor Sales (2019-2030) & (K Unit)
Figure 13. Global C1 Esterase Inhibitor Average Price (USD/Unit) & (2019-2030)
Figure 14. C1 Esterase Inhibitor Report Years Considered
Figure 15. C1 Esterase Inhibitor Sales Share by Manufacturers in 2023
Figure 16. Global C1 Esterase Inhibitor Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest C1 Esterase Inhibitor Players: Market Share by Revenue in 2023
Figure 18. C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global C1 Esterase Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America C1 Esterase Inhibitor Sales Market Share by Country (2019-2030)
Figure 21. North America C1 Esterase Inhibitor Revenue Market Share by Country (2019-2030)
Figure 22. United States C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Mexico C1 Esterase Inhibitor Revenue Growth Rate (2019-2024) & (US$ Million)
Figure 25. Europe C1 Esterase Inhibitor Sales Market Share by Country (2019-2030)
Figure 26. Europe C1 Esterase Inhibitor Revenue Market Share by Country (2019-2030)
Figure 27. Germany C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. UK C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific C1 Esterase Inhibitor Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific C1 Esterase Inhibitor Revenue Market Share by Region (2019-2030)
Figure 34. China C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America C1 Esterase Inhibitor Sales Market Share by Country (2019-2030)
Figure 44. Latin America C1 Esterase Inhibitor Revenue Market Share by Country (2019-2030)
Figure 45. Mexico C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa C1 Esterase Inhibitor Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa C1 Esterase Inhibitor Revenue Market Share by Country (2019-2030)
Figure 51. Turkey C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE C1 Esterase Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of C1 Esterase Inhibitor by Type (2019-2030)
Figure 55. Global Revenue Market Share of C1 Esterase Inhibitor by Type (2019-2030)
Figure 56. Global C1 Esterase Inhibitor Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of C1 Esterase Inhibitor by Application (2019-2030)
Figure 58. Global Revenue Market Share of C1 Esterase Inhibitor by Application (2019-2030)
Figure 59. Global C1 Esterase Inhibitor Price (USD/Unit) by Application (2019-2030)
Figure 60. C1 Esterase Inhibitor Value Chain
Figure 61. C1 Esterase Inhibitor Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of C1 Esterase Inhibitor in 2024?zhanKai
The global market size of C1 Esterase Inhibitor in 2024 was 136 Million USD.
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global C1 Esterase Inhibitor market size from 2024 to 2030?shouQi
What was the global market size of C1 Esterase Inhibitor in 2030?shouQi
Which companies rank high in the global C1 Esterase Inhibitor market?shouQi
den_biaoTiZhungShi

Related Reports

Global C1 Esterase Inhibitor Market Research Report 2024

Industry: Pharma & Healthcare

Published Date: 2024-01-05

Pages: 72 Pages

Report ld: 2139592

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

REPORT SCOPE

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now